According to the data, caspofungin is a beta, which can inhibit the cell wall of susceptible Aspergillus and Candida. The echinocandin synthesized by (1, 3)-D- glucan has an active effect on the active cell growth sites of Candida and Aspergillus fumigatus. Caspofungin acetate for injection is mainly used to treat suspected fungal infection, esophageal candidiasis, other invasive aspergillosis that is ineffective or intolerable to treatment in patients with neutropenia and fever.
Caspofungin has entered the China market for many years, and has become the trump card in the systemic antifungal drug market. It is a first-line antifungal drug recommended by clinical guidelines in various countries and widely listed in the world. In China, the sales market of caspofungin is expanding rapidly.
According to Minenet data, the annual sales of caspofungin injection in China public hospitals in 20021year was 2,475.77 million yuan, with a market growth rate of 6.76%.
The consistency evaluation of caspofungin acetate for injection in Hailing Pharmaceutical Co., Ltd. will be beneficial to the future market sales and enhance the market competitiveness of the drug.
At present, the healthy Yangtze River driven by the two-wheel strategy is entering the fast lane of development. In the field of medicine, Changjiang Health will actively adapt to the national centralized procurement policy, make efforts to enlarge and strengthen antibacterial, antifungal and antiviral drugs, accelerate the continuous innovation of maternal and child drugs, accelerate the internationalization of enterprises, expand product pipelines, and form an online+offline, in-hospital+out-of-hospital, domestic+international development pattern.
Want to know more financial news in real time, please pay attention to us.